1980. – Faculty of Medicine, University of Belgrade; average grade 9.23
1986. – Master's studies in immunology, Faculty of Medicine, University of Belgrade
Master's thesis: "Determination of circulating immune complexes in systemic lupus erythematosus"
1988. – Specialization in internal medicine, Faculty of Medicine, University of Belgrade; specialist exam passed with excellent marks
1993. – Doctorate in medical sciences in rheumatology, Faculty of Medicine, University of Belgrade
Doctoral dissertation: "Significance of capillaroscopic findings for the diagnosis and prognosis of systemic sclerosis"
2001. – Completed subspecialization in rheumatology
Work Experience
Institute of Rheumatology, Belgrade
Faculty of Medicine, University of Belgrade
MediGroup General Hospital, Belgrade
"Da Medika" Polyclinic
Consultant at MediGroup General Hospital, Belgrade
Over 40 years of professional experience in internal medicine and rheumatology
Academic Career
2011. – appointed as a full professor at the University of Belgrade Faculty of Medicine
Retired Full Professor at the University of Belgrade Faculty of Medicine
Participated in teaching, professional development, and mentorship of physicians in internal medicine and rheumatology
Areas of Expertise
Diagnosis and treatment of rheumatic diseases
Systemic connective tissue diseases
Rheumatoid arthritis
Systemic sclerosis
Systemic lupus erythematosus
Osteoporosis
Osteoarthritis
Capillaroscopy
Ultrasound assessment of joint inflammation
Application of biological and targeted therapy in rheumatology
Monitoring cardiovascular risk in patients with rheumatic diseases
Professional Papers and References
Author and co-author of 144 papers published in journals on the SCI and SSCI lists
Damjanov N, Zeković A. “Intra-articular Autologous Conditioned Serum and Triamcinolone Injections in Patients with Knee Osteoarthritis: A Controlled, Randomized, Double-Blind Study.” Journal of International Medical Research, 2023; 51(10).
Robinson MF, Damjanov N, Stamenković B, Radunović G, Kivitz A, Cox L, et al. “Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients with Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.” Arthritis & Rheumatology, 2020; 72(10): 1621–1631.
Damjanov N, Nurmohamed MT, Szekanecz Z. “Biologics, Cardiovascular Effects and Cancer.” BMC Medicine, 2014; 12:48.
Damjanov N, Radunović G, Prodanović S, Vuković V, Milić V, Simić Pašalić K, et al. “Construct Validity and Reliability of Ultrasound Disease Activity Score in Assessing Joint Inflammation in Rheumatoid Arthritis: Comparison with DAS-28.” Rheumatology, 2012; 51(1): 120–128.
Damjanov N, Pavlov-Dolijanović S, Zlatanović M. “Capillaroscopy as a Prognostic Tool for the Development of Connective Tissue Disease in Patients with Raynaud’s Phenomenon.” Reumatizam, 2010; 57(2): 119–120.
Damjanov N, Kauffman RS, Spencer-Green GT. “Efficacy, Pharmacodynamics and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rheumatoid Arthritis: Results of Two Randomized, Double-Blind, Placebo-Controlled Clinical Studies.” Arthritis & Rheumatism, 2009; 60(5): 1232–1241.
Damjanov N, Ostojić P, Kaloudi O, Alari S, Guiducci S, Stanflin N, et al. “Induced Sputum in Systemic Sclerosis Interstitial Lung Disease: Comparison to Healthy Controls and Bronchoalveolar Lavage.” Respiration, 2009; 78(1): 56–62.
